How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Cancer Screening Molecular Tools

Fengting Yan

Pancreatic Cysts - Guidelines Based Management

AdventHealth

V. Shami

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

L. Zheng

mRNA Vaccine in Treatment of Pancreatic Cancer

Houston Methodist

J. Gonzalez

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

GRACE

A. Goodman, A. Jeong, S. Rajeeve

Updates in Perioperative Therapy of Pancreatic Cancer

Horizon CME

P. Philip

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Ut…

2024 ASCO® Annual Meeting Insights Hub

S. Cohen

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

W. Burns

Targeting KRAS in Pancreatic Cancer

Harshabad Singh

ESMO 2024 Summary: Latest Advances in Targeted Therapies for Pancrea…

2024 ESMO Annual Meeting Insights Hub

D. Melisi